NCT02173262View on ClinicalTrials.gov

REaCT Integrated Consent Model to Compare Two Standard of Care Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Breast Cancer
Interventions
DRUG

G-CSF

DRUG

Ciprofloxacin

Trial Locations (1)

K1H 8L6

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER